Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

Prowell TM, Blackford AL, Byrne C, Khouri NF, Dowsett M, Folkerd E, Tarpinian KS, Powers PP, Wright LA, Donehower MG, Jeter SC, Armstrong DK, Emens LA, Fetting JH, Wolff AC, Garrett-Mayer E, Skaar TC, Davidson NE, Stearns V.

Cancer Prev Res (Phila). 2011 Dec;4(12):1993-2001. doi: 10.1158/1940-6207.CAPR-11-0154. Epub 2011 Sep 1.

PMID:
21885816
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, R├╝cklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226.

PMID:
18073378
[PubMed - indexed for MEDLINE]
Free Article
3.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J; ABCSG and the GABG.

Lancet. 2005 Aug 6-12;366(9484):455-62.

PMID:
16084253
[PubMed - indexed for MEDLINE]
Free Article
4.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T; ATAC Trialists' Group.

Lancet. 2002 Jun 22;359(9324):2131-9. Erratum in: Lancet 2002 Nov 9;360(9344):1520.

PMID:
12090977
[PubMed - indexed for MEDLINE]
5.

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators.

Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Erratum in: Lancet. 2014 Mar 22;383(9922):1040.

PMID:
24333009
[PubMed - indexed for MEDLINE]
Free Article
6.

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.

Henry NL, Chan HP, Dantzer J, Goswami CP, Li L, Skaar TC, Rae JM, Desta Z, Khouri N, Pinsky R, Oesterreich S, Zhou C, Hadjiiski L, Philips S, Robarge J, Nguyen AT, Storniolo AM, Flockhart DA, Hayes DF, Helvie MA, Stearns V.

Br J Cancer. 2013 Oct 29;109(9):2331-9. doi: 10.1038/bjc.2013.587. Epub 2013 Oct 1.

PMID:
24084768
[PubMed - indexed for MEDLINE]
7.

Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.

Sanford M, Plosker GL.

Drugs. 2008;68(9):1319-40. Review.

PMID:
18547136
[PubMed - indexed for MEDLINE]
8.

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL.

Menopause. 2007 Nov-Dec;14(6):995-8.

PMID:
17898668
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].

Lu HH, Li Q, Xu BH, Zhang P, Yuan P, Wang JY, Cai RG.

Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):520-5. Chinese.

PMID:
22093630
[PubMed - indexed for MEDLINE]
10.

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

Jahanzeb M.

Clin Ther. 2007 Aug;29(8):1535-47. Review.

PMID:
17919537
[PubMed - indexed for MEDLINE]
11.

Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.

Folkerd EJ, Dixon JM, Renshaw L, A'Hern RP, Dowsett M.

J Clin Oncol. 2012 Aug 20;30(24):2977-80. doi: 10.1200/JCO.2012.42.0273. Epub 2012 Jul 16.

PMID:
22802308
[PubMed - indexed for MEDLINE]
12.

Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.

Olson JA Jr, Budd GT, Carey LA, Harris LA, Esserman LJ, Fleming GF, Marcom PK, Leight GS Jr, Giuntoli T, Commean P, Bae K, Luo J, Ellis MJ.

J Am Coll Surg. 2009 May;208(5):906-14; discussion 915-6. doi: 10.1016/j.jamcollsurg.2009.01.035.

PMID:
19476859
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

Wasan KM, Goss PE, Pritchard PH, Shepherd L, Palmer MJ, Liu S, Tu D, Ingle JN, Heath M, Deangelis D, Perez EA.

Ann Oncol. 2005 May;16(5):707-15. Epub 2005 Apr 7.

PMID:
15817595
[PubMed - indexed for MEDLINE]
Free Article
14.

Focus on anastrozole and breast cancer.

Mokbel K.

Curr Med Res Opin. 2003;19(8):683-8. Review.

PMID:
14687437
[PubMed - indexed for MEDLINE]
15.

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.

Arun B, Valero V, Liu D, Brewster A, Green M, Gutierrez-Barrera A, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N.

Cancer Prev Res (Phila). 2012 Feb;5(2):276-82. doi: 10.1158/1940-6207.CAPR-11-0346. Epub 2011 Nov 18.

PMID:
22102688
[PubMed - indexed for MEDLINE]
16.

'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.

Buzdar AU; ATAC trialists' group.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):399-403.

PMID:
14623537
[PubMed - indexed for MEDLINE]
17.

Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.

Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A'Hern RP, Dowsett M.

J Clin Oncol. 2008 Apr 1;26(10):1671-6. doi: 10.1200/JCO.2007.13.9279.

PMID:
18375896
[PubMed - indexed for MEDLINE]
18.

A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.

Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE.

Breast Cancer Res Treat. 2010 Apr;120(2):427-35. doi: 10.1007/s10549-009-0662-0. Epub 2009 Dec 6.

PMID:
19967558
[PubMed - indexed for MEDLINE]
19.

Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.

Erkanli S, Kayaselcuk F, Kuscu E, Bolat F, Sakalli H, Haberal A.

Breast. 2006 Aug;15(4):558-61. Epub 2005 Nov 28.

PMID:
16311034
[PubMed - indexed for MEDLINE]
20.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.

Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T; ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group.

Cancer. 2003 Nov 1;98(9):1802-10.

PMID:
14584060
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk